Early research (Phase 1)Study completedNCT02434861
What this trial is testing
An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects
Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Tesaro, Inc. 102